Modelling the active SARS-CoV-2 helicase complex as a basis for structure-based inhibitor design (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.11.03.366609
Publication URI: http://dx.doi.org/10.1101/2020.11.03.366609
Type: Preprint